Evidence check: Fertility Check | Fruchtbarkeits-Test in the context of menopause

A 'Fertility Check' or 'Fruchtbarkeits-Test' in the context of menopause requires careful scrutiny. While hormone tests (e.g., AMH, FSH) are clinically validated for assessing ovarian reserve and menopausal transition, direct-to-consumer DNA tests claiming to predict fertility during menopause lack robust evidence. The provided context includes a GWAS entry for rs174546 in the FADS1 gene, associated with lipid and inflammatory markers, but no direct link to fertility or menopause. Other context fragments on DNA tests for metabolism or drug metabolism are not applicable. Menopause is a natural hormonal process; genetic tests cannot reliably predict its timing or remaining fertility. Such tests risk providing false reassurance or unnecessary anxiety. Evidence grade: unclear/marketing. Consumers should rely on clinical hormone assessments and medical guidance.